Systematic review: Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality.
Tenenbaum
Alexander
A
Sackler Faculty of Medicine, Tel-Aviv University, Israel. altenen@post.tau.ac.il
Fisman
Enrique Z
EZ